InvestorsHub Logo
Followers 5
Posts 2466
Boards Moderated 0
Alias Born 08/16/2016

Re: None

Thursday, 04/27/2017 4:43:01 PM

Thursday, April 27, 2017 4:43:01 PM

Post# of 20617
Information to ponder...

"Innovus Pharmaceuticals, Inc. engages in the commercialization, licensing, and development of non-prescription medicine, and consumer care products for health and vitality, and respiratory diseases. It also provides packaged healthcare solutions through over-the-counter, medicines and consumer and health products, which it market directly or through commercial partners to primary care physicians, urologists, gynecologists and therapists, and directly to consumers through on-line channels, retailers and wholesalers. The company business model leverages the ability to acquire and in-license commercial products that are supported by scientific, and or clinical evidence, place them through it existing supply chain, retail and on-line channels. The company was founded on January 15, 1959 and is headquartered in San Diego, CA. "

1. Did you notice the multiple typos in the above article? (You can find that article on marketwatch.)

2. Notice how the article focuses on mistakenly explaining flubbed up "distribution channels" and not on explaining the actual products and growth for the future.

3. Notice how the company has been in business since 1959 and still isn't profitable...

4. Innovus should be renamed Infamous as in, it will be become "infamous" and terrible how our investment money was stolen and they never turned a profit and then went either out of business or "dormant" like OVIT.

5. At the very least, Innovous Pharmaceuticals, should be renamed as Innovous Therapeutics, or better yet, Innovous Sugar-pills.

6. Innovus needs to advertise on Google and Radio.

7. Innovous Pharmaceuticals, new corporate slogan should be
"Seeking FDA Fluticare approval since 1959."

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.